Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: A multi-institutional pooled analysis.

Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: A multi-institutional pooled analysis.

<h4>Background</h4>Radiotherapy is increasingly used to treat oligometastatic patients. We sought to identify prognostic criteria in oligometastatic patients undergoing definitive hypofractionated image-guided radiotherapy (HIGRT).<h4>Methods</h4>Exclusively extracranial olig...

Full description

Bibliographic Details
Main Authors:	Julian C Hong, Diandra N Ayala-Peacock, Jason Lee, A William Blackstock, Paul Okunieff, Max W Sung, Ralph R Weichselbaum, Johnny Kao, James J Urbanic, Michael T Milano, Steven J Chmura, Joseph K Salama
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2018-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0195149

Similar Items

Radiotherapy for Oligometastatic Lung Cancer
by: Derek P. Bergsma, et al.
Published: (2017-09-01)

Stereotactic Ablative Radiotherapy for Oligometastatic Disease in Liver
by: Myungsoo Kim, et al.
Published: (2014-01-01)

The utility of FDG-PET for assessing outcomes in oligometastatic cancer patients treated with stereotactic body radiotherapy: a cohort study
by: Solanki Abhishek A, et al.
Published: (2012-12-01)

CyberKnife Stereotactic Ablative Radiotherapy for Recurrent or Oligometastatic Gynecological Cancers
by: Tejinder Kataria, et al.
Published: (2021-04-01)

A Review of Ongoing Trials of Stereotactic Ablative Radiotherapy for Oligometastatic Cancers: Where Will the Evidence Lead?
by: Faiez Al-Shafa, et al.
Published: (2019-06-01)

Cost-Effectiveness Analysis of Stereotactic Ablative Body Radiotherapy for the Treatment of Oligometastatic Tumors versus Standard of Care
by: Adam J. N. Raymakers, et al.
Published: (2021-05-01)

Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): Study protocol for a randomized phase II trial
by: Palma David A, et al.
Published: (2012-07-01)

Long‐term disease control and survival observed after stereotactic ablative body radiotherapy for oligometastatic breast cancer
by: N. Ari Wijetunga, et al.
Published: (2021-08-01)

A Call for the Aggressive Treatment of Oligometastatic and Oligo-Recurrent Non-Small Cell Lung Cancer
by: Pretesh R. Patel, et al.
Published: (2012-01-01)

Stereotactic ablative body radiotherapy (SABR) for bone only oligometastatic breast cancer: A prospective clinical trial
by: Steven David, et al.
Published: (2020-02-01)

Radiotherapy of oligometastatic prostate cancer: a systematic review
by: Paul Rogowski, et al.
Published: (2021-03-01)

Hypofractionated radiotherapy for primary or secondary oligometastatic lung cancer using Tomotherapy
by: Chang Heng-Jui, et al.
Published: (2012-12-01)

Extracranial Stereotactic Body Radiotherapy in Oligometastatic or Oligoprogressive Breast Cancer
by: Fabian Weykamp, et al.
Published: (2020-06-01)

Role of Radiosurgery/Stereotactic Radiotherapy in Oligometastatic Disease: Brain Oligometastases
by: Rosario Mazzola, et al.
Published: (2019-04-01)

Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Spine Metastases: An Overview
by: Kang Liang Zeng, et al.
Published: (2019-05-01)

Endoscopic nodal staging in oligometastatic non-small cell lung cancer (NSCLC) being treated with stereotactic ablative radiotherapy (ENDO-SABR)
by: Dhaliwal, I., et al.
Published: (2022)

Knowing When to Use Stereotactic Ablative Radiation Therapy in Oligometastatic Cancer
by: Franceschini D, et al.
Published: (2021-09-01)

Cost-Effectiveness Analysis of Local Ablation and Surgery for Liver Metastases of Oligometastatic Colorectal Cancer
by: Matthias F. Froelich, et al.
Published: (2021-03-01)

Stereotactic Radiotherapy in the Treatment of Paraneoplastic Vasculitis in Oligometastatic Renal Cell Carcinoma
by: Laura Burgess, et al.
Published: (2021-05-01)

Stereotactic Body Radiotherapy for Oligometastatic Disease in Non-small Cell Lung Cancer
by: Caryn Wujanto, et al.
Published: (2019-11-01)

Efficacy of PSMA PET-Guided Radiotherapy for Oligometastatic Castrate-Resistant Prostate Cancer
by: Christoph Henkenberens, et al.
Published: (2021-04-01)

Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial
by: David A. Palma, et al.
Published: (2019-08-01)

Stereotactic ablative radiotherapy for the comprehensive treatment of 1–3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial
by: Robert Olson, et al.
Published: (2020-05-01)

Radiotherapy for patients with locoregional and oligometastatic relapses of prostate cancer after radical prostatectomy
by: P. V. Bulychkin, et al.
Published: (2020-11-01)

Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients
by: Laila König, et al.
Published: (2020-02-01)

Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases
by: Rosanna Yeung, et al.
Published: (2017-06-01)

PSMA-11-PET/CT versus choline-PET/CT to guide stereotactic ablative radiotherapy for androgen deprivation therapy deferral in patients with oligometastatic prostate cancer
by: Charlotte L. Deijen, et al.
Published: (2021-09-01)

Stereotactic body radiotherapy for moderately central and ultra-central oligometastatic disease: Initial outcomes
by: Rosie Cooke, et al.
Published: (2020-03-01)

Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Lung Nodules: A Single Institution Series
by: Rodney E. Wegner, et al.
Published: (2019-05-01)

Worth a local treatment? – Analysis of modern radiotherapy concepts for oligometastatic prostate cancer
by: M. Oertel, et al.
Published: (2018-09-01)

Stereotactic Body Radiotherapy for Patients with Lung Oligometastatic Disease: A Five-Year Systematic Review
by: Guillaume Virbel, et al.
Published: (2021-07-01)

Stereotactic body radiotherapy improves the survival of patients with oligometastatic non‐small cell lung cancer
by: Wen Ouyang, et al.
Published: (2019-08-01)

Phase II study of concomitant radiotherapy with atezolizumab in oligometastatic soft tissue sarcomas: STEREOSARC trial protocol
by: Nicolas Penel, et al.
Published: (2020-09-01)

68Ga-PSMA-PET/CT-based radiosurgery and stereotactic body radiotherapy for oligometastatic prostate cancer.
by: Goda Kalinauskaite, et al.
Published: (2020-01-01)

Long-Term Disease-Free Survival of a Patient with Oligometastatic Nasopharyngeal Carcinoma Treated with Radiotherapy Alone
by: Gail Wan Ying Chua, et al.
Published: (2018-06-01)

Complete biochemical response following metastasis-directed radiotherapy for oligometastatic prostate cancer: A case report
by: Satoshi Okuda, et al.
Published: (2020-11-01)

Comparison of 3D confromal radiotherapy and intensity modulated radiotherapy with or without simultaneous integrated boost during concurrent chemoradiation for locally advanced head and neck cancers.
by: Michael T Spiotto, et al.
Published: (2014-01-01)

Local High-Dose Radiotherapy Induces Systemic Immunomodulating Effects of Potential Therapeutic Relevance in Oligometastatic Breast Cancer
by: Elena Muraro, et al.
Published: (2017-11-01)

Efficacy and safety of microwave ablation in the treatment of patients with oligometastatic non-small-cell lung cancer: a retrospective study
by: Zhigang Wei, et al.
Published: (2019-01-01)

Oligometastatic disease - optimal treatment for long-term survival
by: J. Cortés
Published: (2021-04-01)